Douglas Ingram

2020

In 2020, Douglas Ingram earned a total compensation of $1.3M as President and Chief Executive Officer at Sarepta Therapeutics, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$605,475
Salary$669,250
Other$17,222
Total$1,291,947

Ingram received $669.3K in salary, accounting for 52% of the total pay in 2020.

Ingram also received $605.5K in non-equity incentive plan and $17.2K in other compensation.

Rankings

In 2020, Douglas Ingram's compensation ranked 7,513th out of 13,090 executives tracked by ExecPay. In other words, Ingram earned more than 42.6% of executives.

ClassificationRankingPercentile
All
7,513
out of 13,090
43rd
Division
Manufacturing
3,161
out of 5,617
44th
Major group
Chemicals And Allied Products
1,272
out of 2,248
43rd
Industry group
Drugs
1,099
out of 1,948
44th
Industry
Pharmaceutical Preparations
820
out of 1,453
44th

Pay ratio

Douglas Ingram's Pay$1,291,947
Median Employee's Pay$275,247
Pay Ratio

5

to 1

In 2020, the annual total compensation of Douglas Ingram was $1,291,947.

The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.

The ratio of Douglas Ingram's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 20, 2021.

Ingram's colleagues

We found seven more compensation records of executives who worked with Douglas Ingram at Sarepta Therapeutics in 2020.

2020

Louise Rodino-Klapac

Sarepta Therapeutics

Chief Scientific Officer

2020

David Howton

Sarepta Therapeutics

General Counsel

2020

Ian Estepan

Sarepta Therapeutics

Chief Financial Officer

2020

Gilmore MMSc

Sarepta Therapeutics

Chief Scientific Officer

2020

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2020

Joseph Bratica

Sarepta Therapeutics

Vice President, Corporate Controller

2020

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

News

You may also like